Scenario name,Rate of gonorrhea cases,"% cases successfully treated with CIP, TET, or CRO",% cases successfully treated with CIP,% cases successfully treated with TET,% cases successfully treated with CRO,"Effective lifespan of CIP, TET, and CRO",Effective lifespan of CIP,Effective lifespan of TET,Effective lifespan of CRO,delta - Rate of gonorrhea cases,"delta - Effective lifespan of CIP, TET, and CRO",delta - Effective lifespan of CIP,delta - Effective lifespan of TET,delta - Effective lifespan of CRO
Status quo (no rapid test),"7,067 (5,823, 8,010)","53.3% (45.1%, 59.5%)","0.0% (0.0%, 0.0%)","0.0% (0.0%, 0.0%)","53.3% (45.1%, 59.5%)","13.3 (11.3, 14.9)","0.0 (0.0, 0.0)","0.0 (0.0, 0.0)","13.3 (11.3, 14.9)",,,,,
"(p=(0.980, 0.750), q=(0.980, 0.975), c=0.500)","7,276 (5,956, 8,320)","64.0% (50.6%, 71.6%)","18.9% (13.7%, 24.1%)","1.9% (1.2%, 2.6%)","43.3% (34.7%, 48.5%)","16.0 (12.6, 17.9)","4.7 (3.4, 6.0)","0.5 (0.3, 0.7)","10.8 (8.7, 12.1)","2.9% (1.1%, 5.4%)","20.2% (8.2%, 33.7%)","nan% (nan%, nan%)","nan% (nan%, nan%)","-18.6% (-27.3%, -6.0%)"
"(p=(0.980, 0.750), q=(0.980, 0.975), c=0.750)","7,417 (6,124, 8,445)","65.3% (52.9%, 75.4%)","28.7% (19.6%, 36.1%)","2.8% (1.8%, 3.9%)","33.7% (25.6%, 39.4%)","16.3 (13.2, 18.9)","7.2 (4.9, 9.0)","0.7 (0.5, 1.0)","8.4 (6.4, 9.8)","4.9% (1.9%, 7.3%)","22.6% (10.2%, 41.6%)","nan% (nan%, nan%)","nan% (nan%, nan%)","-36.5% (-50.0%, -22.1%)"
"(p=(0.980, 0.750), q=(0.980, 0.975), c=1.000)","7,557 (6,209, 8,672)","65.5% (50.6%, 78.0%)","38.1% (27.0%, 50.1%)","3.7% (2.3%, 5.4%)","23.7% (14.2%, 31.9%)","16.4 (12.7, 19.5)","9.5 (6.8, 12.5)","0.9 (0.6, 1.4)","5.9 (3.6, 8.0)","6.9% (4.3%, 9.9%)","22.9% (11.1%, 36.9%)","nan% (nan%, nan%)","nan% (nan%, nan%)","-55.3% (-73.9%, -36.8%)"
